Myofibroblasts: Biochemical and proteomic approaches to fibrosis

Tohoku Journal of Experimental Medicine

Volumn 230, Issue 2, 2013, Pages 67-73

  Honda, Eiko ^a   Park, Ah Mee ^a   Yoshida, Koji ^b   Tabuchi, Masaki ^b   Munakata, Hiroshi ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

Fibrosis; Myofibroblast; Proteome; Smooth muscle actin; Transforming growth factor

Indexed keywords

5' METHYLTHIOADENOSINE; ALPHA SMOOTH MUSCLE ACTIN; ALPHA TROPOMYOSIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIFIBROTIC AGENT; BETA TROPOMYOSIN; CALDESMON; CALPAIN SMALL SUBUNIT 1; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 2 RECEPTOR; CELL PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYOSIN REGULATORY LIGHT POLYPEPTIDE 2; PROFILIN I; PROTEOME; REACTIVE OXYGEN METABOLITE; RETINOL; RHO KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSGELIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO ACID SEQUENCE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL TRANSDIFFERENTIATION; CHRONIC PANCREATITIS; CYTOKINE RELEASE; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROSIS; GLOMERULONEPHRITIS; HUMAN; INTRACELLULAR SIGNALING; LIVER CIRRHOSIS; LUNG FIBROSIS; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW;

ANIMALS; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; KIDNEY DISEASES; LUNG DISEASES, INTERSTITIAL; MYOFIBROBLASTS; PROTEOME; PROTEOMICS; SCLEROSIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84879049488     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.230.67     Document Type: Review

References (56)

1. Artaud-Macari, E., Goven, D., Brayer, S., Hamimi, A., Besnard, V., Marchal-Somme, J., Ali, Z.E., Crestani, B., Kerdine-Römer, S., Boutten, A. & Bonay, M. (2013) Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibro- blastic dedifferentiation in idiopathic pulmonary fibrosis. Antioxid Redox Signal., 18, 66-79.
2. Barnes, J.L. & Gorin, Y. (2011) Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int., 79, 944-956.
3. Baum, J. & Duffy, H.S. (2011) Fibroblasts and myofibroblasts: what are we talking about? J. Cardiovasc. Pharmacol., 57, 376-379.
4. Border, W.A., Okuda, S., Languino, L.R., Sporn, M.B. & E. Honda et al. Ruoslahti, E. (1990) Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature, 346, 371-374.
5. Brenner, D.A. (2009) Molecular pathogenesis of liver fibrosis. Trans. Am. Clin. Climatol. Assoc., 120, 361-368.
6. Desmoulière, A. (1995) Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol. Int., 19, 471-476.
7. Gerolymos, M., Karagianni, F., Papasotiriou, M., Kalliakmani, P., Sotsiou, F., Charonis, A. & Goumenos, D.S. (2011) Expression of transgelin in human glomerulonephritis of various etiology. Nephron Clin. Pract., 119, c74-c82.
8. Goodwin, A. & Jenkins, G. (2009) Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis. Biochem. Soc. Trans., 37, 849-854.
9. Hinz, B., Phan, S.H., Thannickal, V.J., Galli, A., Bochaton-Piallat, M.L. & Gabbiani, G. (2007) The myofibroblast: one function, multiple origins. Am. J. Pathol., 170, 1807-1816.
10. Holmes, A., Abraham, D.J., Sa, S., Shiwen, X., Black, C.M. & Leask, A. (2001) CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J. Biol. Chem, 276, 10594-10601.
11. Ihn, H. (2002) Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr. Opin. Rheumatol., 14, 681-685.
12. Itoh, K., Ishii, T., Wakabayashi, N. & Yamamoto, M. (1999) Regulatory mechanisms of cellular response to oxidative stress. Free Radic. Res., 31, 319-324.
13. Itoh, K., Mimura, J. & Yamamoto, M. (2010) Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxid. Redox Signal., 13, 1665-1678.
14. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., O'Connor, T. & Yamamoto, M. (2003) Keap1 regulates both cytoplasmic nuclear shuttling and degradation of Nrf2 in response to trophiles. Genes Cells, 8, 379-391.
15. Jacobs, J.P., Jones, C.M. & Baille, J.P. (1970) Characteristics of a human diploid cell designated MRC-5. Nature, 227, 168-170.
16. Julien, B., Grenard, P., Teixeira-Clerc, F., Van Nhieu, J.T., Li, L., Karsak, M., Zimmer, A., Mallat, A. & Lotersztajn, S. (2005) Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology, 128, 742-755.
17. Kawada, N., Kristensen, D.B., Asahina, K., Nakatani, K., Minamiyama, Y., Seki, S. & Yoshizato, K. (2001) Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cells. J. Biol. Chem., 276, 25318-25323.
18. Kisseleva, T. & Brenner, D.A. (2011) Anti-fibrogenic strategies and the regression of fibrosis. Best Pract. Res. Clin. Gastroenterol., 25, 305-317.
19. Knittel, T., Mehde, M., Kobold, D., Saile, B., Dinter, C. & Ramadori, G. (1999) Expression patterns of matrix metallo- proteinases and their inhibitors in parenchymal and non- parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J. Hepatol., 30, 48-60.
20. Kondrikov, D., Caldwell, R.B., Dong, Z. & Su, Y. (2011) Reactive oxygen species-dependent RhoA activation mediates collagen synthesis in hyperoxic lung fibrosis. Free Radic. Biol. Med., 50, 1689-1698.
21. Korfei, M., Schmitt, S., Ruppert, C., Henneke, I., Markart, P., Loeh, B., Mahavadi, P., Wygrecka, M., Klepetko, W., Fink, L., Bonniaud, P., Preissner, K.T., Lochnit, G., Schaefer, L., Seeger, W. & Guenther, A. (2011) Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs. J. Proteome Res., 10, 2185-2205.
22. Leemans, J.C., Butter, L.M., Pulskens, W.P., Teske, G.J., Claessen, N., van der Poll, T. & Florquin, S. (2009) The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One, 4, e5704.
23. Li, Z.B., Kollias, H.D. & Wagner, K.R. (2008) Myostatin directly regulates skeletal muscle fibrosis. J. Biol. Chem., 283, 19371-19378.
24. MacKenna, D., Summerour, S.R. & Villarreal, F.J. (2000) Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc. Res., 46, 257-263.
25. Malmström, J., Lindberg, H., Lindberg, C., Bratt, C., Wieslander, E., Delander, E.L., Särnstrand, B., Burns, J.S., Mose-Larsen, P., Fey, S. & Marko-Varga, G. (2004) Transforming growth factor-beta 1 specifically induce proteins involved in the myofibroblast contractile apparatus. Mol. Cell. Proteomics., 3, 466-477.
26. Malmström, J., Tufvesson, E., Löfdahl, C.G., Hansson, L., Marko- Varga, G. & Westergren-Thorsson, G. (2003) Activation of platelet-derived growth factor pathway in human asthmatic pulmonary-derived mesenchymal cells. Electrophoresis, 24, 276-285.
27. Margadant, C. & Sonnenberg, A. (2010) Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep., 11, 97-105
28. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. & Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
29. Motohashi, H. & Yamamoto, M. (2004) Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med., 10, 549-557.
30. Mölleken, C., Sitek, B., Henkel, C., Poschmann, G., Sipos, B., Wiese, S., Warscheid, B., Broelsch, C., Reiser, M., Friedman, S.L., Tornøe, I., Schlosser, A., Klöppel, G., Schmiegel, W., Meyer, H.E., Holmskov, U. & Stühler, K. (2009) Detection of novel biomarkers of liver cirrhosis by proteomic analysis. ec-Hepatology, 49, 1257-1266.
31. Munro, S., Thomas, K.L. & Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
32. Ohtsuji, M., Katsuoka, F., Kobayashi, A., Aburatani, H., Hayes, J.D. & Yamamoto, M. (2008) Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J. Biol. Chem., 283, 33554-33562.
33. Park, A.M., Hayakawa, S., Honda, E., Mine, Y., Yoshida, K. & Munakata, H. (2012) Conditioned media from lung cancer cell line A549 and PC9 inactivate pulmonary fibroblasts by regulating protein phosphorylation. Arch. Biochem. Biophys., 518, 133-141.
34. Piera-Velazquez, S., Li, Z. & Jimenez, S.A. (2011) Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am. J. Pathol., 179, 1074-1080.
35. Powell, D.W., Mifflin, R.C., Valentich, J.D., Crowe, S.E., Saada, J.I. & West, A.B. (1999) Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol., 277, C1-C9.
36. Reisdorf, P., Lawrence, D.A., Sivan, V., Klising, E. & Martin, M.T. (2001) Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis. Am. J. Pathol., 159, 263-272.
37. Rodríguez-Iturbe, B. & García García, G. (2010) The role of tubu- lointerstitial inflammation in the progression of chronic renal failure. Nephron Clin. Pract., 116, c81-c88.
38. Sakurai, T., Kudo, M., Fukuta, N., Nakatani, T., Kimura, M., Park, A.M. & Munakata, H. (2011) Involvement of angiotensin II and reactive oxygen species in pancreatic fibrosis. Pancre- atology, 11 Suppl 2, 7-13.
39. Santibañez, J.F., Quintanilla, M. & Bernabeu, C. (2011) TGF-6/ TGF-6 receptor system and its role in physiological and pathological conditions. Clin. Sci. (Lond), 121, 233-251.
40. Scotton, C.J. & Chambers, R.C. (2007) Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest, 132, 1311-1321.
41. Seki, E., De Minicis, S., Osterreicher, C.H., Kluwe, J., Osawa, Y., Brenner, D.A. & Schwabe, R.F. (2007) TLR4 enhances TGFbeta signaling and hepatic fibrosis. Nat. Med., 13, 1324-1332.
42. Senoo, H., Yoshikawa, K., Morii, M., Miura, M., Imai, K. & Mezaki, Y. (2010) Hepatic stellate cell (vitamin A-storing cell) and its relative - past, present and future. Cell Biol. Int., 34, 1247-1272.
43. Shimizu, Y., Dobashi, K., Iizuka, K., Horie, T., Suzuki, K., Tukagoshi, H., Nakazawa, T., Nakazato, Y. & Mori, M. (2001) Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis. Am. J. Respir. Crit. Care Med., 163, 210-217.
44. Shimizukawa, M., Ebina, M., Narumi, K., Kikuchi, T., Munakata, H. & Nukiwa, T. (2003) Intratracheal gene transfer of decorin reduces subpleural fibroproliferation induced by bleomycin. Am. J. Physiol. Lung Cell. Mol. Physiol., 284, L526-L532.
45. Tanjore, H., Cheng, D.S., Degryse, A.L., Zoz, D.F., Abdolrasulnia, R., Lawson, W.E. & Blackwell, T.S. (2011) Alveolar epithelial cells undergo epithelial-to-mesenchymal transition in response to endoplasmic reticulum stress. J. Biol. Chem., 286, 30972-30980.
46. Teixeira-Clerc, F., Julien, B., Grenard, P., Tran Van Nhieu, J., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A. & Lotersztajn, S. (2006) CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat. Med., 12, 671-676.
47. Thakur, S., Du, J., Hourani, S., Ledent, C. & Li, J.M. (2010) Inactivation of adenosine A2A receptor attenuates basal and angiotensin II-induced ROS production by Nox2 in endothelial cells. J. Biol. Chem., 285, 40104-40113.
48. Tsang, S.W., Ip, S.P. & Leung, P.S. (2004) Prophylactic and therapeutic treatments with AT 1 and AT 2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int. J. Biochem. Cell Biol., 36, 330-339.
49. Wang, W., Koka, V. & Lan, H.Y. (2005) Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Cartion), 10, 48-56.
50. Watai, Y., Kobayashi, A., Nagase, H., Mizukami, M., McEvoy, J., Singer, J.D., Itoh, K. & Yamamoto, M. (2007) Subcellular localization and cytoplasmic complex status of endogenous Keap1. Genes Cells, 12, 1163-1178.
51. Wu, H.Z., Guo, L., Mak, Y.F., Liu, N., Poon, W.T., Chan, Y.W. & Cai, Z. (2011) Proteomics investigation on aristolochic acid nephropathy: a case study on rat kidney tissues. Anal. Bioanal. Chem., 399, 3431-3439.
52. Wynn, T.A. (2008) Cellular and molecular mechanisms of fibrosis. J. Pathol., 214, 199-210.
53. Yin, G., Yan, C. & Berk, B.C. (2003) Angiotensin II signaling pathways mediated by tyrosine kinases. Int. J. Biochem. Cell Biol., 35, 780-783.
54. Yoshida, K. & Munakata, H. (2007) Connective tissue growth factor binds to fibronectin through the type I repeat modules and enhances the affinity of fibronectin to fibrin. Biochim. Biophys. Acta, 1770, 672-680.
55. Yoshizaki, A., Iwata, Y., Komura, K., Ogawa, F., Hara, T., Muroi, E., Takenaka, M., Shimizu, K., Hasegawa, M., Fujimoto, M., Tedder, T.F. & Sato, S. (2008) CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin- induced scleroderma. Am. J. Pathol., 172, 1650-1663.
56. Zhou, H.M., Wang, J., Elliott, C., Wen, W., Hamilton, D.W. & Conway, S.J. (2010) Spatiotemporal expression of periostin during skin development and incisional wound healing: lessons for human fibrotic scar formation. J. Cell Commun. Signal., 4, 99-107.